US Stock MarketDetailed Quotes

ALRN Aileron Therapeutics

Watchlist
  • 1.7500
  • -0.0100-0.57%
Close Dec 20 16:00 ET
37.92MMarket Cap-0.61P/E (TTM)

Aileron Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
207.08%6.07M
334.57%9.04M
80.62%7.21M
-44.49%15.35M
55.26%7.3M
-69.50%1.98M
-74.13%2.08M
-52.63%3.99M
3.92%27.65M
-31.00%4.7M
Selling and administrative expenses
20.15%2.35M
179.87%5.3M
71.73%3.74M
17.32%11.36M
131.64%5.33M
-12.84%1.96M
-27.42%1.89M
-13.81%2.18M
0.86%9.68M
2.04%2.3M
-General and administrative expense
20.15%2.35M
179.87%5.3M
71.73%3.74M
17.32%11.36M
131.64%5.33M
-12.84%1.96M
-27.42%1.89M
-13.81%2.18M
0.86%9.68M
2.04%2.3M
Research and development costs
16,818.18%3.72M
1,900.53%3.74M
91.33%3.46M
-77.79%3.99M
-17.90%1.97M
-99.48%22K
-96.56%187K
-69.29%1.81M
5.64%17.97M
-47.34%2.4M
Operating profit
-207.08%-6.07M
-334.57%-9.04M
-80.62%-7.21M
44.49%-15.35M
-55.26%-7.3M
69.50%-1.98M
74.13%-2.08M
52.63%-3.99M
-3.92%-27.65M
31.00%-4.7M
Net non-operating interest income expense
400K
Non-operating interest income
----
----
----
--400K
----
----
----
----
----
----
Other net income (expense)
49.33%224K
-66.89%97K
111.65%92K
-328.93%-728K
-213.39%-381K
3,650.00%150K
293K
-3,490.91%-790K
-27.89%318K
373.24%336K
Gain on sale of security
----
----
----
--200K
----
----
----
----
----
----
Special income (charges)
--0
--0
--0
---928K
--12K
---6K
--88K
---1.02M
--0
--0
-Less：Restructuring and merger&acquisition
--0
--0
--0
--928K
---12K
--6K
---88K
--1.02M
--0
--0
Other non- operating income (expenses)
43.59%224K
-52.68%97K
-60.34%92K
----
----
3,800.00%156K
--205K
1,154.55%232K
-27.89%318K
373.24%336K
Income before tax
-220.03%-5.85M
-400.39%-8.94M
-48.84%-7.11M
42.64%-15.68M
-60.17%-7.28M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
Income tax
Net income
-220.03%-5.85M
-400.39%-8.94M
-48.84%-7.11M
42.64%-15.68M
-60.17%-7.28M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
Net income continuous Operations
-220.03%-5.85M
-400.39%-8.94M
-48.84%-7.11M
42.64%-15.68M
-60.17%-7.28M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
Minority interest income
Net income attributable to the parent company
-220.03%-5.85M
-400.39%-8.94M
-48.84%-7.11M
42.43%-15.73M
-61.40%-7.34M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-220.03%-5.85M
-400.39%-8.94M
-48.84%-7.11M
42.43%-15.73M
-61.40%-7.34M
71.31%-1.83M
77.64%-1.79M
43.26%-4.78M
-4.45%-27.33M
33.12%-4.55M
Basic earnings per share
32.50%-0.27
-15.38%-0.45
18.10%-0.86
43.19%-3.42
-57.00%-1.57
71.43%-0.4
77.84%-0.39
43.55%-1.05
-2.21%-6.02
32.89%-1
Diluted earnings per share
32.50%-0.27
-15.38%-0.45
18.10%-0.86
43.19%-3.42
-57.00%-1.57
71.43%-0.4
77.84%-0.39
43.55%-1.05
-2.21%-6.02
32.89%-1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 207.08%6.07M334.57%9.04M80.62%7.21M-44.49%15.35M55.26%7.3M-69.50%1.98M-74.13%2.08M-52.63%3.99M3.92%27.65M-31.00%4.7M
Selling and administrative expenses 20.15%2.35M179.87%5.3M71.73%3.74M17.32%11.36M131.64%5.33M-12.84%1.96M-27.42%1.89M-13.81%2.18M0.86%9.68M2.04%2.3M
-General and administrative expense 20.15%2.35M179.87%5.3M71.73%3.74M17.32%11.36M131.64%5.33M-12.84%1.96M-27.42%1.89M-13.81%2.18M0.86%9.68M2.04%2.3M
Research and development costs 16,818.18%3.72M1,900.53%3.74M91.33%3.46M-77.79%3.99M-17.90%1.97M-99.48%22K-96.56%187K-69.29%1.81M5.64%17.97M-47.34%2.4M
Operating profit -207.08%-6.07M-334.57%-9.04M-80.62%-7.21M44.49%-15.35M-55.26%-7.3M69.50%-1.98M74.13%-2.08M52.63%-3.99M-3.92%-27.65M31.00%-4.7M
Net non-operating interest income expense 400K
Non-operating interest income --------------400K------------------------
Other net income (expense) 49.33%224K-66.89%97K111.65%92K-328.93%-728K-213.39%-381K3,650.00%150K293K-3,490.91%-790K-27.89%318K373.24%336K
Gain on sale of security --------------200K------------------------
Special income (charges) --0--0--0---928K--12K---6K--88K---1.02M--0--0
-Less：Restructuring and merger&acquisition --0--0--0--928K---12K--6K---88K--1.02M--0--0
Other non- operating income (expenses) 43.59%224K-52.68%97K-60.34%92K--------3,800.00%156K--205K1,154.55%232K-27.89%318K373.24%336K
Income before tax -220.03%-5.85M-400.39%-8.94M-48.84%-7.11M42.64%-15.68M-60.17%-7.28M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M
Income tax
Net income -220.03%-5.85M-400.39%-8.94M-48.84%-7.11M42.64%-15.68M-60.17%-7.28M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M
Net income continuous Operations -220.03%-5.85M-400.39%-8.94M-48.84%-7.11M42.64%-15.68M-60.17%-7.28M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M
Minority interest income
Net income attributable to the parent company -220.03%-5.85M-400.39%-8.94M-48.84%-7.11M42.43%-15.73M-61.40%-7.34M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -220.03%-5.85M-400.39%-8.94M-48.84%-7.11M42.43%-15.73M-61.40%-7.34M71.31%-1.83M77.64%-1.79M43.26%-4.78M-4.45%-27.33M33.12%-4.55M
Basic earnings per share 32.50%-0.27-15.38%-0.4518.10%-0.8643.19%-3.42-57.00%-1.5771.43%-0.477.84%-0.3943.55%-1.05-2.21%-6.0232.89%-1
Diluted earnings per share 32.50%-0.27-15.38%-0.4518.10%-0.8643.19%-3.42-57.00%-1.5771.43%-0.477.84%-0.3943.55%-1.05-2.21%-6.0232.89%-1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List